2Elisabeth P, Thomas S, Maria P, et al. Cytokine profile and correlation to the APACHE Ⅲ and MPM Ⅱ scores in patients with sepsis. Am J Respir Crit Care Med,1997,156:825-832.
3Janeway CA, Travers P, Walport M, et al.Autoimmunity and transplantation. Immunobiology 5th. New York: Garland Publishing,2001. 501-551.
5Ginaldi L, De Martinis M, Modesti M, et al.Immunophenotypical changes of T lymphocytes in the elderly. Gerontology, 2000,46: 242-248.
6Hynninen, Marja, Pettila , et al. Predictive value of monocyte histocompatibility leukocyte antigen-DR expression and plasma interleukin-4 and -10 levels in critically ill patients with sepsis. Shock,2003,20:1-4.
7Mentula P, Kylanpaa-Back ML, Kemppainen E,et al.Decreased HLA ( human leucocyte antigen )-DR expression on peripheral blood monocytes predicts the development of organ failure in patients with acute pancreatitis. Clin Science, 2003,105:409-417.
8Saenz J J, Izura J J, Manrique A, et al. Early prognosis in severe sepsis via analysing the monocyte immunophenotype. Int Care Med,2001,27: 970-977.
9Oczenski W, Krenn H, Jilch R, et al. HLA-DR as a marker for increased risk for systemic inflammation and septic complications after cardiac surgery. Int Care Med, 2003,29:1253-1257.
10William GC. The human leukocyte antigens and their relationship to infection. Am J Surgery, 1993, 165(Suppl) :75S-81S.
二级参考文献2
1J. C. Marshall. Clinical trials of mediator-directed therapy in sepsis: what have we learned?[J] 2000,Intensive Care Medicine(1):S075～S083
2H. -D. Volk,P. Reinke,D. Krausch,H. Zuckermann,K. Asadullah,J. M. Müller,W. -D. D?cke,W. J. Kox. Monocyte deactivation-rationale for a new therapeutic strategy in sepsis[J] 1996,Intensive Care Medicine(4):S474～S481
2Lekkou A, Karakantza M, Mouzaki A, et al. Cytokine Production and monocyte HLA - DR expression as predictors of outcome for patients with community -acquired severe infections [ J]. Clin Diagn Lab Imu- munol,2004,11 ( 1 ) : 161 - 167.
